Navigation Links
Varian Medical Systems Supports Program to Tap Brain Power of Research and Development Community in Russia
Date:2/11/2013

MOSCOW, Feb. 11, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), the world leader in radiotherapy and radiosurgery, is working with key development agencies in Russia to encourage the country's leading research institutes and scientists to collaborate on research and development proposals for programs aimed at advancing radiotherapy technology. 

"The leading technologists within Varian have defined five future development opportunities and will entertain research proposals that address these challenges from scientists in Russia's R&D community," says Scott Johnson , Varian's senior manager of research collaborations, who is coordinating Varian's support for the project. "This is a new type of process for Varian and we are looking forward to supporting forward-thinking, next-generation research that could well be developed and commercialized."

Varian has contributed $50,000 to this venture, which will be combined with other funds equaling $100K in prize money for the team or teams with the best proposals. 

The program presents the Russian R&D community with the opportunity to take a focused look at the needs of radiotherapy.  "We believe this will yield significant benefits to cancer patients not only in Russia but throughout the world. Russia was the first country to put a man into space and it has a deep, sophisticated technological base in radiation technologies," Johnson says.

The topics specified by Varian technologists include new solutions for treatment planning, new technologies in brachytherapy, new ways of detecting targets on computed tomography and magnetic resonance images, designs for compact and low cost proton accelerators, and new target materials and designs for converting electron beams to megavoltage X-ray beams.

The program, which runs over the next six months, is also receiving support from the Skolkovo Foundation, a not-for-profit, government-funded organization that was launched in 2010 as part of the Kremlin's efforts to create an innovation ecosystem that is intended as Russia's answer to Silicon Valley.

Varian will assess R&D proposals with the Skolkovo Foundation,and the Rusnano Foundation for Infrastructure and Educational Programs (FIEP), which develops and supports Russia's integration with global leaders.

"Varian is the international leader in radiotherapy with centers of excellence all over the world," says Dow Wilson, chief executive officer of Varian. "With this innovative program we are engaging the strengths of the Russian R&D community that can be brought to this network for the benefit of cancer patients everywhere."

Varian in Russian Federation
More than 30 Varian medical linear accelerators are installed in Russian cancer clinics and the company currently supplies up to 20 new treatment systems each year to radiotherapy departments in the country. 

Editorial contact: Neil Madle , Varian Medical Systems, +44 7786 526068

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications.  Varian Medical Systems employs approximately 6,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.


'/>"/>
SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cell Therapeutics Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
2. Varian Equipment Selected to Equip New Cancer Center in Algeria and Enable More Advanced Radiotherapy Treatments for Patients
3. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2013
4. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
5. Varian Medical Systems to Exhibit New Wireless Flat Panel Detector, Image Processing Software and X-Ray Tubes for Digital Radiography at RSNA
6. Varian Medical Systems to Showcase Advanced Technologies for Treating Cancer with Image-Guided Radiotherapy and Radiosurgery at JASTRO Meeting in Tokyo, Japan
7. Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer
8. Varian Medical Systems to Exhibit Flat Panel Detectors, X-Ray Tubes and Imaging Software Optimized for Digital Radiography at MEDICA
9. The Nairobi Hospital in Kenya Commences Treating Cancer with Advanced Radiotherapy Delivery Using Varian Equipment and Software
10. Varian Medical Systems Management to Present at Jefferies 2012 Global Healthcare Conference
11. Varian Medical Systems Management to Present at Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
Breaking Medicine News(10 mins):